APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Soliris Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Soliris Drug Market Outlook and Growth Opportunities 2026

Report ID 174036840422 December 2025194 pages

Choose your research edition.

Industry ResearchSoliris Drug Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Soliris Drug Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Soliris Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soliris Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Soliris Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Soliris Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Soliris Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Soliris Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soliris Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Soliris Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Soliris Drug market include AstraZeneca. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Soliris Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soliris Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soliris Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soliris Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Soliris Drug Segment by Company

AstraZeneca

Soliris Drug Segment by Type

Plasma Exchange

Plasma Infusion

Soliris Drug Segment by Application

PNH

aHUS

Other

Soliris Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Soliris Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Soliris Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Soliris Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Soliris Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soliris Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soliris Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soliris Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Soliris Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Soliris Drug industry.

Chapter 3: Detailed analysis of Soliris Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Soliris Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Soliris Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Soliris Drug Industry Trends Table 2. Soliris Drug Industry Drivers Table 3. Soliris Drug Industry Opportunities and Challenges Table 4. Soliris Drug Industry Restraints Table 5. Global Soliris Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Soliris Drug Revenue Share by Company (2021-2026) Table 7. Global Soliris Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Soliris Drug Sales Volume Share by Company (2021-2026) Table 9. Global Soliris Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Soliris Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Soliris Drug Key Company Manufacturing Base & Headquarters Table 12. Global Soliris Drug Company, Product Type & Application Table 13. Global Soliris Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Soliris Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plasma Exchange Table 18. Significant Companies of Plasma Infusion Table 19. Global Soliris Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Soliris Drug Sales Volume by Type (2021-2026) & (k units) Table 21. Global Soliris Drug Sales Volume by Type (2027-2032) & (k units) Table 22. Global Soliris Drug Sales Volume Share by Type (2021-2026) Table 23. Global Soliris Drug Sales Volume Share by Type (2027-2032) Table 24. Global Soliris Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Soliris Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Soliris Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Soliris Drug Sales Value Share by Type (2021-2026) Table 28. Global Soliris Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of PNH Table 30. Significant Companies of aHUS Table 31. Significant Companies of Other Table 32. Global Soliris Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Soliris Drug Sales Volume by Application (2021-2026) & (k units) Table 34. Global Soliris Drug Sales Volume by Application (2027-2032) & (k units) Table 35. Global Soliris Drug Sales Volume Share by Application (2021-2026) Table 36. Global Soliris Drug Sales Volume Share by Application (2027-2032) Table 37. Global Soliris Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Soliris Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Soliris Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Soliris Drug Sales Value Share by Application (2021-2026) Table 41. Global Soliris Drug Sales Value Share by Application (2027-2032) Table 42. Global Soliris Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Soliris Drug Sales by Region (2021-2026) & (k units) Table 44. Global Soliris Drug Sales Market Share by Region (2021-2026) Table 45. Global Soliris Drug Sales by Region (2027-2032) & (k units) Table 46. Global Soliris Drug Sales Market Share by Region (2027-2032) Table 47. Global Soliris Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Soliris Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Soliris Drug Sales Value Share by Region (2021-2026) Table 50. Global Soliris Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Soliris Drug Sales Value Share by Region (2027-2032) Table 52. Global Soliris Drug Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Soliris Drug Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Soliris Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Soliris Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Soliris Drug Sales by Country (2021-2026) & (k units) Table 57. Global Soliris Drug Sales Market Share by Country (2021-2026) Table 58. Global Soliris Drug Sales by Country (2027-2032) & (k units) Table 59. Global Soliris Drug Sales Market Share by Country (2027-2032) Table 60. Global Soliris Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Soliris Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Soliris Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Soliris Drug Sales Value Market Share by Country (2027-2032) Table 64. AstraZeneca Company Information Table 65. AstraZeneca Business Overview Table 66. AstraZeneca Soliris Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. AstraZeneca Soliris Drug Product Portfolio Table 68. AstraZeneca Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Soliris Drug Distributors List Table 72. Soliris Drug Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Soliris Drug Product Image Figure 2. Global Soliris Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Soliris Drug Sales (2021-2032) & (k units) Figure 5. Global Soliris Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Soliris Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plasma Exchange Image Figure 10. Plasma Infusion Image Figure 11. Global Soliris Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Soliris Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Soliris Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Soliris Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Soliris Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Soliris Drug Sales Value Share by Type (2021-2032) Figure 17. PNH Image Figure 18. aHUS Image Figure 19. Other Image Figure 20. Global Soliris Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Soliris Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Soliris Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Soliris Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Soliris Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Soliris Drug Sales Value Share by Application (2021-2032) Figure 26. Global Soliris Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Soliris Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Soliris Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Soliris Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Soliris Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Soliris Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Soliris Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Soliris Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Soliris Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Soliris Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Soliris Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Soliris Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Soliris Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Soliris Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Soliris Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Exchange
  • Plasma Infusion
Applications
  • PNH
  • aHUS
  • Other
Companies covered
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Soliris Drug Sales Value (2021-2032)
  4. 1.2.2 Global Soliris Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Soliris Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Soliris Drug Market Dynamics
  1. 2.1 Soliris Drug Industry Trends
  2. 2.2 Soliris Drug Industry Drivers
  3. 2.3 Soliris Drug Industry Opportunities and Challenges
  4. 2.4 Soliris Drug Industry Restraints
3 Soliris Drug Market by Company
  1. 3.1 Global Soliris Drug Company Revenue Ranking in 2025
  2. 3.2 Global Soliris Drug Revenue by Company (2021-2026)
  3. 3.3 Global Soliris Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Soliris Drug Average Price by Company (2021-2026)
  5. 3.5 Global Soliris Drug Company Ranking (2024-2026)
  6. 3.6 Global Soliris Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Soliris Drug Company Product Type and Application
  8. 3.8 Global Soliris Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Soliris Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Soliris Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Soliris Drug Market by Type
  1. 4.1 Soliris Drug Type Introduction
  2. 4.1.1 Plasma Exchange
  3. 4.1.2 Plasma Infusion
  4. 4.2 Global Soliris Drug Sales Volume by Type
  5. 4.2.1 Global Soliris Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Soliris Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Soliris Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Soliris Drug Sales Value by Type
  9. 4.3.1 Global Soliris Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Soliris Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Soliris Drug Sales Value Share by Type (2021-2032)
5 Soliris Drug Market by Application
  1. 5.1 Soliris Drug Application Introduction
  2. 5.1.1 PNH
  3. 5.1.2 aHUS
  4. 5.1.3 Other
  5. 5.2 Global Soliris Drug Sales Volume by Application
  6. 5.2.1 Global Soliris Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Soliris Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Soliris Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Soliris Drug Sales Value by Application
  10. 5.3.1 Global Soliris Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Soliris Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Soliris Drug Sales Value Share by Application (2021-2032)
6 Soliris Drug Regional Sales and Value Analysis
  1. 6.1 Global Soliris Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Soliris Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Soliris Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Soliris Drug Sales by Region (2027-2032)
  5. 6.3 Global Soliris Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Soliris Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Soliris Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Soliris Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Soliris Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Soliris Drug Sales Value (2021-2032)
  12. 6.6.2 North America Soliris Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Soliris Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Soliris Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Soliris Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Soliris Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Soliris Drug Sales Value (2021-2032)
  21. 6.9.2 South America Soliris Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Soliris Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Soliris Drug Sales Value Share by Country, 2025 VS 2032
7 Soliris Drug Country-level Sales and Value Analysis
  1. 7.1 Global Soliris Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Soliris Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Soliris Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Soliris Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Soliris Drug Sales by Country (2027-2032)
  6. 7.4 Global Soliris Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Soliris Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Soliris Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Soliris Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Soliris Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Soliris Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Soliris Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Soliris Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Soliris Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Soliris Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Soliris Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Soliris Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Soliris Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Soliris Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Soliris Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Soliris Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Soliris Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Soliris Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Soliris Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Soliris Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Soliris Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Soliris Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Soliris Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Soliris Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Soliris Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Soliris Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Soliris Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Soliris Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Soliris Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Soliris Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Soliris Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Soliris Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Soliris Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Soliris Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Soliris Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Soliris Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Soliris Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Soliris Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Soliris Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Soliris Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Soliris Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Soliris Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Soliris Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Soliris Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Soliris Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Soliris Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Soliris Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Soliris Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Soliris Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Soliris Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Soliris Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Soliris Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Soliris Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Soliris Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Soliris Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Soliris Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Soliris Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Soliris Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Soliris Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Soliris Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Soliris Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Soliris Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Soliris Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Soliris Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Soliris Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Soliris Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Soliris Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Soliris Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Soliris Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Soliris Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Soliris Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Soliris Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Soliris Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Soliris Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Soliris Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Soliris Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Soliris Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Soliris Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Soliris Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Soliris Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Soliris Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Soliris Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Soliris Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Soliris Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Soliris Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Soliris Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Soliris Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Soliris Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Soliris Drug Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Soliris Drug Value Chain Analysis
  2. 9.1.1 Soliris Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Soliris Drug Sales Mode & Process
  6. 9.2 Soliris Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Soliris Drug Distributors
  9. 9.2.3 Soliris Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst